FAIL (the browser should render some flash content, not this).


Intelligent Bio-Systems

News and Investor Relations
FAIL (the browser should render some flash content, not this).




Home
Investor Relations

IBS is well funded through both knowledgable  investors and Government grants.  Investor inquiries are welcome.

Click here for company contact information

IBS closes a round of funding.
IBS has recently closed a round of funding which in combination with five Government grants will help it produce and place prototype instruments in the field.




Recent News - Intelligent Bio-Systems, Inc.

April 6, 2011

IBS' Proprietary Sequencing Technology featured in NHGRI Conference. CEO and Founder Dr. Steven Gordon is a principal investigator in a National Human Genome Research Institute (NHGRI) grant for the development of advanced sequencing technology (see Sept. 14, 2010 news below). He described some of the Company's work in a key meeting of sequencign technlogy developers in San Diego.
read more
 

March 18, 2011

IBS's New Diagnostic Sequencing System Unveiled during XGEN Conference.  CEO and Founder,  Dr. Steven Gordon described the unique design and significant cost and performance advantages of IBS's new MINI sequencer for research and diagnostic applications.
read more
 

September 14, 2010

IBS Awarded $2.6 Million NIH Grant as Part of the $1,000 Genome Initiative
from the National Human Genome Research Institute  for "Third Generation DNA Sequencing Technology."
read more
 

February 8, 2011

New US Patent 7,883,869 issued as part of IBS's exclusively licensed IP portfolio.  IBS' Founder, Dr. Jingyue Ju and his team at Columbia University were awarded a US patent entitled "Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators" related on the use of a unique method for reducing the cost of next generation sequencing by synthesis.
read more
 

September 7, 2010

New US Patent 7,790,869 issued as part of IBS' exclusively licensed IP Protfolio. Company's Founder, Dr. Jingyue Ju and his team at Columbia University were awarded a US patent entitled "Massive parallel method for decoding DNA and RNA" related on the use of cleavable blocking groups and dyes using almost any cleaving method.
read more
 



Archived News



January 15, 2007

George Church Joins IBS Scientific Advisory Board. Dr George Church is a renowned expert and innovator in DNA sequencing and many other important molecular biology methods. He has developed breakthrough DNA synthesis and sequencing technologies and has a longstanding relationship with a number of IBS's key scientists.

  
December 31, 2006

Founder's article voted to top 50. Founder Dr. Jingyue Ju's article in December 26th edition of the Proceedings of the National Academy of Sciences was voted one of the top 50 articles in December.
read more
 
December 11, 2006

IBS completes Exclusive License with Columbia University. The license includes significant number of issued and pending patents for worldwide markets

read more
 
October 4, 2006

IBS Awarded NIH Grant
from the National Human Genome Research Institute  for "Near-Term Development  for Genome Sequencing."

read more